ACE2 and COVID-19: Since this could provide useful therapeutic approaches against COVID-19 (coronavirus disease 2019), we investigated the mutational landscape of the Spike RBD with the ACE2 host–cell receptor or different antibodies displayed over the ferritin nanocages.